BB Biotech’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $61.1M | Buy |
3,400,000
+116,728
| +4% | +$2.1M | 1.54% | 22 |
|
|
2018
Q4 | $41.7M | Buy |
3,283,272
+292,860
| +10% | +$3.72M | 1.34% | 23 |
|
|
2018
Q3 | $64.1M | Buy |
2,990,412
+330,000
| +12% | +$7.08M | 1.7% | 20 |
|
|
2018
Q2 | $54.9M | Buy |
2,660,412
+60,000
| +2% | +$1.24M | 1.59% | 18 |
|
|
2018
Q1 | $65.4M | Hold |
2,600,412
| – | – | 1.81% | 17 |
|
|
2017
Q4 | $49.4M | Buy |
2,600,412
+200,000
| +8% | +$3.8M | 1.39% | 17 |
|
|
2017
Q3 | $44.4M | Buy |
2,400,412
+50,300
| +2% | +$930K | 1.23% | 18 |
|
|
2017
Q2 | $41.2M | Buy |
2,350,112
+90,112
| +4% | +$1.58M | 1.26% | 18 |
|
|
2017
Q1 | $42M | Buy |
2,260,000
+340,000
| +18% | +$6.32M | 1.38% | 18 |
|
|
2016
Q4 | $39.2M | Buy |
1,920,000
+465,000
| +32% | +$9.5M | 1.45% | 16 |
|
|
2016
Q3 | $43.5M | Buy |
1,455,000
+935,000
| +180% | +$28M | 1.53% | 18 |
|
|
2016
Q2 | $14M | Buy |
+520,000
| New | +$14M | 0.55% | 23 |
|